1 asset in Trophoblastic Neoplasm
Therapeutic assets addressing Trophoblastic Neoplasm, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Nivolumab Trophoblastic Neoplasm | Instituto do Cancer do Estado de São Paulo | P2 | CCC (53) |